Eung Bae Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eung Bae Lee has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Sukki Cho
Department of Thoracic and Cardiovascular Surgery, Seoul National University School of Medicine, Seoul, Republic of Korea
5 shared publicationsYangki Seok
Lung Cancer Center, Kyungpook National University Medical Center, Daegu, Republic of Korea
3 shared publications- Byeongju Kang
Department of Surgery, School of Medicine, Kyungpook National University, Daegu 41566, Republic of Korea
1 shared publication Chang Ho Kim
Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
1 shared publication- Chang Ho Kim
Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea
1 shared publication Cheng Cheng Jin
Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea
1 shared publication
Latest Publications
- Open Access
Association of BTRC rs10883617 with Survival Outcomes in Surgically Resected Non-Small Cell Lung Cancer
Background/Objectives: Genetic variation in components of the ubiquitin–proteasome system may contribute to cancer progression and clinical outcomes. This study investigated whether potentially functional variants in E3 ubiquitin ligase-related genes are associated with survival outcomes after surgical resection of non-small cell lung cancer (NSCLC). Methods: The study included 744 Korean patients with stage I–IIIA NSCLC, divided into discovery and validation cohorts. Fifty-one potentially functional single-nucleotide polymorphisms in E3 ubiquitin ligase-related genes were evaluated for associations with overall survival (OS) and disease-free survival (DFS). Results: Among the polymorphisms examined, BTRC rs10883617 T>C was significantly associated with DFS in the validation cohort, whereas the association with OS showed a concordant trend but did not reach statistical significance. In the combined cohort, carriers of at least one C allele had significantly better OS (HR = 0.55, 95% CI = 0.34–0.90, p = 0.02) and DFS (HR = 0.64, 95% CI = 0.46–0.89, p = 0.01) than patients with the TT genotype. The C allele demonstrated significantly lower promoter activity than the T allele in A549 and H1299 lung cancer cell lines (both p < 0.01). BTRC mRNA expression was significantly higher in tumor tissues than in paired non-neoplastic tissues (p < 0.001), but did not differ by genotype. Conclusions: Collectively, BTRC rs10883617 T>C was associated with favorable survival outcomes and allele-specific promoter activity in surgically resected NSCLC. However, its effect on endogenous BTRC expression remains unconfirmed in this patient population. Independent external validation and further mechanistic studies are warranted.
Open AccessAssociation of BTRC rs10883617 with Survival Outcomes in Surgically Resected Non-Small Cell Lung Cancer
Background/Objectives: Genetic variation in components of the ubiquitin–proteasome system may contribute to cancer progression and clinical outcomes. This study investigated whether potentially functional variants in E3 ubiquitin ligase-related genes are associated with survival outcomes after surgical resection of non-small cell lung cancer (NSCLC). Methods: The study included 744 Korean patients with stage I–IIIA NSCLC, divided into discovery and validation cohorts. Fifty-one potentially functional single-nucleotide polymorphisms in E3 ubiquitin ligase-related genes were evaluated for associations with overall survival (OS) and disease-free survival (DFS). Results: Among the polymorphisms examined, BTRC rs10883617 T>C was significantly associated with DFS in the validation cohort, whereas the association with OS showed a concordant trend but did not reach statistical significance. In the combined cohort, carriers of at least one C allele had significantly better OS (HR = 0.55, 95% CI = 0.34–0.90, p = 0.02) and DFS (HR = 0.64, 95% CI = 0.46–0.89, p = 0.01) than patients with the TT genotype. The C allele demonstrated significantly lower promoter activity than the T allele in A549 and H1299 lung cancer cell lines (both p < 0.01). BTRC mRNA expression was significantly higher in tumor tissues than in paired non-neoplastic tissues (p < 0.001), but did not differ by genotype. Conclusions: Collectively, BTRC rs10883617 T>C was associated with favorable survival outcomes and allele-specific promoter activity in surgically resected NSCLC. However, its effect on endogenous BTRC expression remains unconfirmed in this patient population. Independent external validation and further mechanistic studies are warranted.
- Open Access
- 17 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7226
Management of Breast Phyllodes Tumors: A Grade-Stratified Surgical and Reconstructive Strategy
Background: Phyllodes tumors (PTs) are rare fibroepithelial breast neoplasms spanning a benign-to-malignant spectrum, and the extent of surgery and reconstruction differs markedly by histologic grade. The primary aim of this study was to derive a grade-stratified surgical and reconstructive algorithm. Methods: The charts of patients diagnosed with phyllodes tumor at Kyungpook National University Chilgok Hospital between January 2011 and February 2026 were retrospectively reviewed. Tumors were classified by World Health Organization criteria as benign, borderline, or malignant, and the treatment protocols, extent of surgery, and immediate reconstruction after mastectomy were analyzed. Results: Of 417 patients charted, 401 were confirmed to have phyllodes tumors and 334 carried a definitive histologic grade. Together, they formed the analyzed cohort: 251 benign (75.1%), 55 borderline (16.5%), and 28 malignant (8.4%). Benign tumors were managed predominantly by breast-conserving surgery (BCS). Twenty-six patients formed the surgical cohort, defined by the reconstructive requirement of the resection defect: all total mastectomies (n = 19) together with all breast-conserving resections reconstructed by the plastic surgical team (oncoplastic breast-conserving surgery, n = 7). Reconstruction was performed in 21 (80.8%) with latissimus dorsi-based flaps, local flaps, or direct-to-implant reconstruction. Adjuvant radiotherapy was confined to malignant disease (7 of 15 malignant PTs, 46.7%; p = 0.010). Over a median follow-up of 32.7 months, local recurrence developed in four patients (15.4%) and two malignant tumors were fatal. In an illustrative case of recurrent malignant PT with rib metastasis, a widely opened pleural cavity was sealed with a single sheet of non-fenestrated acellular dermal matrix (ADM), which was found to be fully incorporated and still sealing the pleura at later implant explantation. Conclusions: A grade-stratified strategy (BCS for benign tumors and mastectomy with reconstruction for borderline/malignant disease) balances oncologic safety with aesthetic outcome.
- 17 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7226
Open AccessManagement of Breast Phyllodes Tumors: A Grade-Stratified Surgical and Reconstructive Strategy
Background: Phyllodes tumors (PTs) are rare fibroepithelial breast neoplasms spanning a benign-to-malignant spectrum, and the extent of surgery and reconstruction differs markedly by histologic grade. The primary aim of this study was to derive a grade-stratified surgical and reconstructive algorithm. Methods: The charts of patients diagnosed with phyllodes tumor at Kyungpook National University Chilgok Hospital between January 2011 and February 2026 were retrospectively reviewed. Tumors were classified by World Health Organization criteria as benign, borderline, or malignant, and the treatment protocols, extent of surgery, and immediate reconstruction after mastectomy were analyzed. Results: Of 417 patients charted, 401 were confirmed to have phyllodes tumors and 334 carried a definitive histologic grade. Together, they formed the analyzed cohort: 251 benign (75.1%), 55 borderline (16.5%), and 28 malignant (8.4%). Benign tumors were managed predominantly by breast-conserving surgery (BCS). Twenty-six patients formed the surgical cohort, defined by the reconstructive requirement of the resection defect: all total mastectomies (n = 19) together with all breast-conserving resections reconstructed by the plastic surgical team (oncoplastic breast-conserving surgery, n = 7). Reconstruction was performed in 21 (80.8%) with latissimus dorsi-based flaps, local flaps, or direct-to-implant reconstruction. Adjuvant radiotherapy was confined to malignant disease (7 of 15 malignant PTs, 46.7%; p = 0.010). Over a median follow-up of 32.7 months, local recurrence developed in four patients (15.4%) and two malignant tumors were fatal. In an illustrative case of recurrent malignant PT with rib metastasis, a widely opened pleural cavity was sealed with a single sheet of non-fenestrated acellular dermal matrix (ADM), which was found to be fully incorporated and still sealing the pleura at later implant explantation. Conclusions: A grade-stratified strategy (BCS for benign tumors and mastectomy with reconstruction for borderline/malignant disease) balances oncologic safety with aesthetic outcome.
- 1 August 2017
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (11) , 3386-3395
Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer
This study was conducted to determine whether single-nucleotide polymorphisms (SNPs) in EMT-related genes may influence the prognosis of NSCLC after surger
- 1 August 2017
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 24 (11) , 3386-3395
Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer
This study was conducted to determine whether single-nucleotide polymorphisms (SNPs) in EMT-related genes may influence the prognosis of NSCLC after surger
- 12 August 2016
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 66 (02) , 150-155
Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller
Background This study analyzed the impact of visceral pleural invasion (VPI) on the disease-free survival (DFS) of patients with partly solid pulmonary adenocarcinoma sized 30 mm or smaller. Method This is a retrospective study of 147 patients with surgically resected pathologic N0 pulmonary adenocarcinoma that had a partly solid appearance on preoperative computed tomography. All patients presented with tumors of size 30 mm or smaller. The DFS rate was estimated using Kaplan–Meier method. A multivariate analysis for prognostic factors was performed using the Cox proportional hazards regression model. Results VPI was found in 36 patients. The 5-year DFS in 111 patients without VPI (97.6%) was significantly higher than that in 36 patients with VPI (63%) (p < 0.0001). Univariate analysis revealed three significant poor prognostic predictors: the presence of VPI, the presence of lymphovascular invasion, and the size of the solid component on computed tomography (>20, ≤30 mm). According to the multivariate analysis, VPI was found to be a significant poor prognostic predictor (hazard ratio for DFS = 7.31, 95% confidence interval = 1.444–37.014, p = 0.016). Conclusion VPI is a significant predictor of poor prognosis for small-sized (≤30 mm) partly solid lung adenocarcinoma. Therefore, upstaging of the T factor from T1 to T2 on the basis of VPI as described by the TNM staging system is mandatory regardless of ground-glass opacity in small lung adenocarcinoma.
- 12 August 2016
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon
- Vol. 66 (02) , 150-155
Visceral Pleural Invasion Is a Significant Prognostic Factor in Patients with Partly Solid Lung Adenocarcinoma Sized 30 mm or Smaller
Background This study analyzed the impact of visceral pleural invasion (VPI) on the disease-free survival (DFS) of patients with partly solid pulmonary adenocarcinoma sized 30 mm or smaller. Method This is a retrospective study of 147 patients with surgically resected pathologic N0 pulmonary adenocarcinoma that had a partly solid appearance on preoperative computed tomography. All patients presented with tumors of size 30 mm or smaller. The DFS rate was estimated using Kaplan–Meier method. A multivariate analysis for prognostic factors was performed using the Cox proportional hazards regression model. Results VPI was found in 36 patients. The 5-year DFS in 111 patients without VPI (97.6%) was significantly higher than that in 36 patients with VPI (63%) (p < 0.0001). Univariate analysis revealed three significant poor prognostic predictors: the presence of VPI, the presence of lymphovascular invasion, and the size of the solid component on computed tomography (>20, ≤30 mm). According to the multivariate analysis, VPI was found to be a significant poor prognostic predictor (hazard ratio for DFS = 7.31, 95% confidence interval = 1.444–37.014, p = 0.016). Conclusion VPI is a significant predictor of poor prognosis for small-sized (≤30 mm) partly solid lung adenocarcinoma. Therefore, upstaging of the T factor from T1 to T2 on the basis of VPI as described by the TNM staging system is mandatory regardless of ground-glass opacity in small lung adenocarcinoma.
- Open Access
- 26 May 2016
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 11 (1) , 1-2
Inadvertently transected left superior pulmonary vein during thoracoscopic left lower lobectomy
There are several anatomical variations of the pulmonary vein which can cause serious complications in pulmonary lobectomy. We inadvertently divided the left superior pulmonary vein during thoracoscopic left lower lobectomy in a lung cancer patient. Retrospective review of the preoperative computed tomography showed extra-pericardial common trunk of the left pulmonary venous system. Left superior pulmonary vein was reimplanted into stump of divided common trunk via thoracotomy. Awareness of vascular anomalies will help thoracic surgeons to prevent potential morbidity and mortality from complications.
- 26 May 2016
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 11 (1) , 1-2
Open AccessInadvertently transected left superior pulmonary vein during thoracoscopic left lower lobectomy
There are several anatomical variations of the pulmonary vein which can cause serious complications in pulmonary lobectomy. We inadvertently divided the left superior pulmonary vein during thoracoscopic left lower lobectomy in a lung cancer patient. Retrospective review of the preoperative computed tomography showed extra-pericardial common trunk of the left pulmonary venous system. Left superior pulmonary vein was reimplanted into stump of divided common trunk via thoracotomy. Awareness of vascular anomalies will help thoracic surgeons to prevent potential morbidity and mortality from complications.
- Open Access
- 1 January 2013
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Korean Journal of Hepato-Biliary-Pancreatic Surgery
- Vol. 17 (2) , 86-88
Delayed presentation of traumatic diaphragmatic rupture with complicated cholecystitis
The right-sided diaphragmatic rupture is often clinically occulted due to buffering effects of the liver and thus, erroneous diagnosis of such rupture may result in life-threatening conditions. A 44-year-old female who had a history of car accident in 2006 was admitted to our hospital for pleuritic pain. On the chest computed tomography, she was diagnosed with diaphragmatic rupture accompanied by herniation of hypertrophic left liver with complicated cholecystitis and we carried out cholecystectomy, reduction of the liver, pleural drainage, and primary closure of the diaphragm via thoracic approaches. Our case is presented in three unique aspects: herniation of left hemiliver, hypertrophic liver herniated up to the 4th rib level, and combination of complicated cholecystitis. Although the diagnosis of right-sided diaphragmatic rupture can be challenging for the surgeon, an early diagnosis can prevent further complications on the clinical presentation.
- 1 January 2013
- Published by The Korean Association of Hepato-Biliary-Pancreatic Surgery in Korean Journal of Hepato-Biliary-Pancreatic Surgery
- Vol. 17 (2) , 86-88
Open AccessDelayed presentation of traumatic diaphragmatic rupture with complicated cholecystitis
The right-sided diaphragmatic rupture is often clinically occulted due to buffering effects of the liver and thus, erroneous diagnosis of such rupture may result in life-threatening conditions. A 44-year-old female who had a history of car accident in 2006 was admitted to our hospital for pleuritic pain. On the chest computed tomography, she was diagnosed with diaphragmatic rupture accompanied by herniation of hypertrophic left liver with complicated cholecystitis and we carried out cholecystectomy, reduction of the liver, pleural drainage, and primary closure of the diaphragm via thoracic approaches. Our case is presented in three unique aspects: herniation of left hemiliver, hypertrophic liver herniated up to the 4th rib level, and combination of complicated cholecystitis. Although the diagnosis of right-sided diaphragmatic rupture can be challenging for the surgeon, an early diagnosis can prevent further complications on the clinical presentation.
- 11 September 2010
- Published by Springer Nature in Surgical Endoscopy
- Vol. 25 (4) , 1054-1061
Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung cancer
To promote the broad use of video-assisted thoracic surgery (VATS) for lobectomy (VATSL) in the management of lung cancer, it should be proved cost-effective, especially in the current cost-sensitive climate. This study evaluated and compared the costs of VATSL and open lobectomy (OL) and analyzed how the surgeon’s experience level with VATSL affected the cost. In this study, 86 patients in a VATSL group and 97 patients in an OL group underwent surgery for lung cancer. Cost comparisons were performed for the VATSL and OL groups between patients who had no complications and patients with and without complications according to tumor location and the learning period of the surgeon. Postoperative complications occurred for 56 patients (30.6%) (14 VATSL vs 42 OL patients; p < 0.05). Patients who underwent VATSL had significant reductions in both chest tube duration (5.4 vs 9.1 days; p = 0.000) and length of hospital stay (7.1 vs 12.0 days; p = 0.000). The mean operation time for VATSL was not significantly longer than for OL (145.8 vs 136.4 min; p = 0.782). The total hospital cost (i.e., that paid by the patient and national insurance combined) was lower for VATSL than for OL according to comparisons both among all patients ($5,391 vs $5,593, respectively) and among only noncomplicated patients ($4,684 vs $4,769, respectively). In terms of tumor location, the total hospital cost for the VATSL group was lower than for the OL group when the surgery was performed on the right lower lobe (RLL), left upper lobe (LUL), and left lower lobe (LLL). The costs were not significantly different between the two learning periods of the surgeons, except for the cost of anesthesia. In Korea, VATSL for lung cancer had lower complication rates, shorter hospital stays, and lower total hospital costs than OL.
- 11 September 2010
- Published by Springer Nature in Surgical Endoscopy
- Vol. 25 (4) , 1054-1061
Comparison of costs for video-assisted thoracic surgery lobectomy and open lobectomy for non-small cell lung cancer
To promote the broad use of video-assisted thoracic surgery (VATS) for lobectomy (VATSL) in the management of lung cancer, it should be proved cost-effective, especially in the current cost-sensitive climate. This study evaluated and compared the costs of VATSL and open lobectomy (OL) and analyzed how the surgeon’s experience level with VATSL affected the cost. In this study, 86 patients in a VATSL group and 97 patients in an OL group underwent surgery for lung cancer. Cost comparisons were performed for the VATSL and OL groups between patients who had no complications and patients with and without complications according to tumor location and the learning period of the surgeon. Postoperative complications occurred for 56 patients (30.6%) (14 VATSL vs 42 OL patients; p < 0.05). Patients who underwent VATSL had significant reductions in both chest tube duration (5.4 vs 9.1 days; p = 0.000) and length of hospital stay (7.1 vs 12.0 days; p = 0.000). The mean operation time for VATSL was not significantly longer than for OL (145.8 vs 136.4 min; p = 0.782). The total hospital cost (i.e., that paid by the patient and national insurance combined) was lower for VATSL than for OL according to comparisons both among all patients ($5,391 vs $5,593, respectively) and among only noncomplicated patients ($4,684 vs $4,769, respectively). In terms of tumor location, the total hospital cost for the VATSL group was lower than for the OL group when the surgery was performed on the right lower lobe (RLL), left upper lobe (LUL), and left lower lobe (LLL). The costs were not significantly different between the two learning periods of the surgeons, except for the cost of anesthesia. In Korea, VATSL for lung cancer had lower complication rates, shorter hospital stays, and lower total hospital costs than OL.
- Open Access
- 1 August 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 11 (2) , 146-149
Management of primary and secondary pneumothorax using a small-bore thoracic catheter
This study aimed to investigate the efficacies and complications associated with the 7F catheter inserted in patients with pneumothorax in the emerge
- 1 August 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 11 (2) , 146-149
Open AccessManagement of primary and secondary pneumothorax using a small-bore thoracic catheter
This study aimed to investigate the efficacies and complications associated with the 7F catheter inserted in patients with pneumothorax in the emerge
- Open Access
- 1 August 2010
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (8) , 1251-1254
Prognostic Factors for Pulmonary Metastasectomy in the Treatment of Hepatocellular Carcinoma
- 1 August 2010
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 5 (8) , 1251-1254
Open AccessPrognostic Factors for Pulmonary Metastasectomy in the Treatment of Hepatocellular Carcinoma
- Open Access
- 5 February 2010
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 43 (1) , 47-52
The Prognostic Factors of Traumatic Diaphragmatic Rupture
Cho S, et al. Korean J Thorac Cardiovasc Surg. 2010 Feb;43(1):47-52. http://dx.doi.org/10.5090/kjtcs.2010.43.1.47
- 5 February 2010
- Published by Korean Society for Thoracic and Cardiovascular Surgery in The Korean Journal of Thoracic and Cardiovascular Surgery
- Vol. 43 (1) , 47-52
Open AccessThe Prognostic Factors of Traumatic Diaphragmatic Rupture
Cho S, et al. Korean J Thorac Cardiovasc Surg. 2010 Feb;43(1):47-52. http://dx.doi.org/10.5090/kjtcs.2010.43.1.47